Writing Group Member	Employment	Research Grant	Other Research Support	Speakers’ Bureau/Honoraria	Expert Witness	Ownership Interest	Consultant/Advisory Board	Other
Gary Gintant	AbbVie, Inc	None	None	None	None	None	None	None
Joseph C. Wu	Stanford University School of Medicine	NIH†; Leducq Fondationt†	None	None	None	Khloris Biosciences†	None	None
Paul Burridge	Northwestern University	None	None	None	None	None	None	None
Lior Gepstein	Technion-Israel Institute of Technology	None	None	None	None	None	None	None
Sian Harding	Imperial College NHLI (United Kingdom)	British Heart Foundation (Centre for Regenerative Medicine)†	None	None	None	None	None	None
Todd Herron	University of Michigan	NIH-SBIR (PI)†	University of Michigan (director of Regeneration Core Laboratory)†	None	None	CARTOX, LLC†	None	CARTOX, LLC (president)†
Charles Hong	University of Maryland School of Medicine	None	None	None	None	None	None	None
Jose Jalife	University of Michigan	None	None	None	None	Cartox LLC*	None	None

This table represents the relationships of writing group members that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all members of the writing group are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

^*

Modest.

^†

Significant.